A simple view of a complex system

Aashish Tater, Head of Research, Fortunewizard.com advises to book profit in JM Financial and re-enter in it at lower levels.

Aashish Tater, Head of Research, Fortunewizard.com advises to exit from TTK Prestige at current levels as there is limited upside in the stock.

VK Sharma, Head Private Broking Wealth Management at HDFC Securities is of the view that Sun Pharma Advanced Research Company can give better returns than Sun Pharmaceutical Industries.

An ex-Ranbaxy Director and Global Head, Research Information & Portfolio Management, Thakur played a key role in providing evidence to the US FDA about the company falsifying data and violating ethical management practices.

Paula Brown Stafford, Global Head, Clinical Development, Quintiles, gives an insight about the challenges of clinical research and how it can be addressed May 20 may be an unexceptional date to most, but to those of us within the clinical research ...

Aashish Tater, Head of Research, Fortunewizard.com recommends to invest in Karur Vysya Bank for 25-30 percent returns in one year.

State Bank of Bikaner and Jaipur (SBBJ) has target of Rs 530 over the next 12-15 months, says Aashish Tater, Head of Research, Fortunewizard.com.

Navigation scientist, G. Satheesh Reddy, has been appointed Director of Research Centre Imarat (RCI), a premier missile research laboratory in Hyderabad. An Outstanding Scientist grade with the RCI, Satheesh will formally take over on Wednesday. He joined the ...

Bhuvnesh Singh, head of research at Barclays Capital says at Barclays they are overweight on healthcare stocks, some pharma stocks like Sun Lupin. They also like Cairn India and BPCL from the oil and gas sector.